Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Elevation Oncology
Thomas Jefferson University
Thomas Jefferson University
Pfizer
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.
Hoffmann-La Roche
NuCana plc